Why SI-Bone Stock Was Crushing It Today
Key Points
The medical device maker posted a satisfying beat-and-raise third quarter.
During the period, it managed to narrow its net loss considerably.
- 10 stocks we like better than SI-Bone ›
Highly specialized medical device company SI-Bone (NASDAQ: SIBN) was looking rather special on the stock market Tuesday. Its shares were flying nearly 18% higher in mid-session action, thanks in large part to an earnings report that featured better-than-expected fundamentals. SI-Bone's rise was well higher than the S&P 500's (SNPINDEX: ^GSPC) 0.3% bump higher at that time.
Fundamentals moving in the right direction
SI-Bone took the wraps off its third-quarter numbers just after market close on Monday, divulging that its revenue was $48.7 million for the period. That represented a very healthy year-over-year increase of almost 21%.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »
Image source: Getty Images.
And although the company posted a net loss of $4.6 million ($0.11 per share) according to generally accepted accounting principles (GAAP), it was narrower than the $6.6 million deficit in the year-ago quarter.
With those figures, SI-Bone edged past the average analyst estimates. These were for revenue of just under $46.7 million, and GAAP net loss of $0.17 per share.
In its earnings release, SI-Bone attributed the improved fundamentals mainly to higher procedure volume. This was aided significantly by a record increase in the number of physicians utilizing the company's wares -- specifically, this metric rose by 27% year over year to 1,530 professionals.
Prediction of a double-digit revenue rise
Investors were also cheered by SI-Bone's raised guidance for the entirety of 2025. The company's top-line projection received a slight lift; it now stands at $198 million to $200 million for the year, representing growth of at least 18% over the 2024 result.
Non-GAAP (adjusted) earnings before interest, taxes, depreciation, and amortization (EBITDA) should be positive. The company did not get more specific. It also didn't provide any bottom-line guidance.
Should you invest $1,000 in SI-Bone right now?
Before you buy stock in SI-Bone, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and SI-Bone wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $604,044!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,220,149!*
Now, it’s worth noting Stock Advisor’s total average return is 1,064% — a market-crushing outperformance compared to 194% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of November 10, 2025
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Recommended Articles
